Employees Retirement System Of Texas Viking Therapeutics, Inc. Transaction History

Employees Retirement System Of Texas

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$2.11 - $3.15 $292,922 - $437,301	-138,826 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$6.55 - $8.6 $359,110 - $471,503	54,826 Added 65.27%	138,826 $955,000
Q4 2018 Feb 12, 2019	BUY	$7.16 - $16.21 $221,960 - $502,510	31,000 Added 58.49%	84,000 $643,000
Q3 2018 Nov 13, 2018	SELL	$9.7 - $19.65 $87,300 - $176,850	-9,000 Reduced 14.52%	53,000 $923,000
Q1 2018 May 11, 2018	BUY	$4.11 - $6.93 $254,820 - $429,660	62,000 New	62,000 $271,000

442

63.3M

6.23M

2.97M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.73B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.